The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment.
Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf
CPE details for GameChangers Podcast March 2021
Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome.
0107-0000-21-097-H01-P
0.25 CEU/2.5 Hrs (Knowledge)
Initial Release Date: 03/02/21
Expiration Date: 03/02/24
Additional CPE information is located at https://www.ceimpact.com/podcast
See omnystudio.com/listener for privacy information.
Learn more about your ad choices. Visit megaphone.fm/adchoices
